This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Potapova, O. Articles by Mercola, D. Search for Related Content PubMed PubMed Citation Articles by Potapova, O. Articles by Mercola, D.

Platelet-derived Growth Factor-B/v-sis Confers a Tumorigenic and Metastatic Phenotype to Human T98G Glioblastoma Cells¹

The Sidney Kimmel Cancer Center, San Diego, California 92121 [O. P., D. M.]; The Center for Molecular Genetics, University of California at San Diego, La Jolla, California 92093 [D. M.]; Division of Neurosurgery, University of California at Los Angeles, Los Angeles, California 90024 [H. F.]; and Veterans Affairs Medical Center, San Diego, California 92161 [S. B.]

Autocrine stimulation by platelet-derived growth factor-B (PDGF-B)-like factors has been widely implicated as an important mechanism in the cause and/or maintenance of a variety of human tumors. However, normal human cells appear to be resistant to transformation by PDGF-B-like molecules, and a direct demonstration of the tumor-promoting or tumor-maintaining property of a PDGF-B autocrine system is lacking. T98G human glioblastoma cells are nontumorigenic in athymic mice. We show that these cells express predominantly PDGF-ß type receptors and continuously secrete small amount of PDGF-B/c-sis. Addition of suramin or specific anti-PDGF-B/v-sis antibody inhibits proliferation in culture. Conversely, multiple clonal lines that stably overexpress PDGF-B/v-sis (T98Gsis cells) exhibit a striking 200–250% increased proliferation rate and an enhanced colony-forming frequency in soft agar. Clonal lines with stable expression of PDGF-B/v-sis (T98Gsis cells) reliably (80%) develop tumors in 4–6 weeks, whereas the empty-vector control cells are nontumorigenic. Moreover, in some cases, T98Gsis cells disseminate to form bilateral and multifocal pulmonary metastases. The results show that T98G cells contain functional PDGF receptors that, upon sufficient stimulation, can cause greatly increased mitogenic response, which may account for the development of the malignant phenotype. Metastatic tumor formation in athymic mice by PDGF stimulation has not been reported previously. The mechanism may depend on preexisting changes such as the lost p53 function of these cells. T98Gsis cells provide a model of growth factor-dependent tumorigenesis and metastases, which may be helpful in elucidating these relationships.

¹ This work was supported by NIH Grant CA 63783 and by Grant 93B06 from the American Institute of Cancer Research (D. M.).

² To whom requests for reprints should be addressed, at Sidney Kimmel Cancer Center, 3099 Science Park Road, Suite 200, San Diego, CA 92121. Phone: (619) 450-5990; Fax: (619) 450-3251.

Received 6/ 8/95. Accepted 11/13/95.

This article has been cited by other articles:

				J. Hayakawa, C. Depatie, M. Ohmichi, and D. Mercola The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair J. Biol. Chem., May 30, 2003; 278(23): 20582 - 20592. [Abstract] [Full Text] [PDF]

				Y.-M. Yang, F. Bost, W. Charbono, N. Dean, R. McKay, J. S. Rhim, C. Depatie, and D. Mercola C-Jun NH2-terminal Kinase Mediates Proliferation and Tumor Growth of Human Prostate Carcinoma Clin. Cancer Res., January 1, 2003; 9(1): 391 - 401. [Abstract] [Full Text] [PDF]

				N. A. Lokker, C. M. Sullivan, S. J. Hollenbach, M. A. Israel, and N. A. Giese Platelet-derived Growth Factor (PDGF) Autocrine Signaling Regulates Survival and Mitogenic Pathways in Glioblastoma Cells: Evidence That the Novel PDGF-C and PDGF-D Ligands May Play a Role in the Development of Brain Tumors Cancer Res., July 1, 2002; 62(13): 3729 - 3735. [Abstract] [Full Text] [PDF]

				J. Liu, R.-H. Xu, Y.-X. Jin, and D.-B. Wang Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription Nucleic Acids Res., February 1, 2001; 29(3): 783 - 791. [Abstract] [Full Text] [PDF]

				C. A. Kruse, S. Visonneau, B. K. Kleinschmidt-DeMasters, C. J. Gup, G. G. Gomez, D. B. Paul, and D. Santoli The Human Leukemic T-Cell Line, TALL-104, Is Cytotoxic to Human Malignant Brain Tumors and Traffics through Brain Tissue: Implications for Local Adoptive Immunotherapy Cancer Res., October 1, 2000; 60(20): 5731 - 5739. [Abstract] [Full Text]

				T. Kilic, J. A. Alberta, P. R. Zdunek, M. Acar, P. Iannarelli, T. O’Reilly, E. Buchdunger, P. M. Black, and C. D. Stiles Intracranial Inhibition of Platelet-derived Growth Factor-mediated Glioblastoma Cell Growth by an Orally Active Kinase Inhibitor of the 2-Phenylaminopyrimidine Class Cancer Res., September 1, 2000; 60(18): 5143 - 5150. [Abstract] [Full Text]

				R. A. Gjerset, S. Lebedeva, A. Haghighi, S. T. Turla, and D. Mercola Inhibition of the Jun Kinase Pathway Blocks DNA Repair, Enhances p53-mediated Apoptosis and Promotes Gene Amplification Cell Growth Differ., August 1, 1999; 10(8): 545 - 554. [Abstract] [Full Text]

				Y. Li, B. Lin, A. Agadir, R. Liu, M. I. Dawson, J. C. Reed, J. A. Fontana, F. Bost, P. D. Hobbs, Y. Zheng, et al. Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines Mol. Cell. Biol., August 1, 1998; 18(8): 4719 - 4731. [Abstract] [Full Text]

				M. A. Schwartz Integrins, Oncogenes, and Anchorage Independence J. Cell Biol., November 3, 1997; 139(3): 575 - 578. [Full Text] [PDF]

				O. Potapova, A. Haghighi, F. Bost, C. Liu, M. J. Birrer, R. Gjerset, and D. Mercola The Jun Kinase/Stress-activated Protein Kinase Pathway Functions to Regulate DNA Repair and Inhibition of the Pathway Sensitizes Tumor Cells to Cisplatin J. Biol. Chem., May 30, 1997; 272(22): 14041 - 14044. [Abstract] [Full Text] [PDF]

				B. Liu, R. S. Maul, and D. M. Kaetzel Jr. Repression of Platelet-derived Growth Factor A-chain Gene Transcription by an Upstream Silencer Element. PARTICIPATION BY SEQUENCE-SPECIFIC SINGLE-STRANDED DNA-BINDING PROTEINS J. Biol. Chem., October 18, 1996; 271(42): 26281 - 26290. [Abstract] [Full Text] [PDF]

				D. Ma, Z. Xing, B. Liu, N. G. Pedigo, S. G. Zimmer, Z. Bai, E. H. Postel, and D. M. Kaetzel NM23-H1 and NM23-H2 Repress Transcriptional Activities of Nuclease-hypersensitive Elements in the Platelet-derived Growth Factor-A Promoter J. Biol. Chem., January 4, 2002; 277(2): 1560 - 1567. [Abstract] [Full Text] [PDF]

				C. Liu, J. Yao, D. Mercola, and E. Adamson The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251 J. Biol. Chem., June 30, 2000; 275(27): 20315 - 20323. [Abstract] [Full Text] [PDF]